Pharma Journalist 8947 posts 0 comments

Boehringer Ingelheim today announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company focused on cancer immunotherapy and advancing…
Read More...

SMi Group reports: Senior expert from iVeena is set to present at SMi’s 3rd Annual Ophthalmic Drugs 3 Day Conference taking place in London on 18 – 20 November 2019. Europe’s leading…
Read More...

SMi Reports: SMi are pleased to share the two-day agenda, the expert speaker line-up and the importance of attending  the inaugural Pharmaceutical Cleanroom Technology Conference The…
Read More...

SOTIO and Cytune Pharma, members of the PPF Group, announce the first dosing of cancer patients with SO-C101, a superagonist fusion protein of interleukin IL-15. The phase I/Ib study…
Read More...

Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, announced that it has entered into…
Read More...

Teva Pharmaceuticals USA, Inc. announced that the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa., which, together with three other…
Read More...

The Blood-Brain Barrier Drug Delivery Summit, or B3DD, will be held in Boston, MA, from August 13-15, 2019. This new Hanson Wade event is aimed at experts looking to deliver CNS drug…
Read More...

Nexus Pharmaceuticals Inc., woman-owned, privately held, US-based healthcare company, announced an agreement with the village of Pleasant Prairie, Wisconsin to build an industry-leading…
Read More...

Jazz Pharmaceuticals plc announced that the company has signed a definitive agreement under which Jazz has acquired Redx Pharma's (Redx) pan-RAF inhibitor program for the potential…
Read More...

The U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for isatuximab for the treatment of patients with relapsed/refractory…
Read More...